1. Introduction {#sec1}
===============

Lower respiratory tract infections such as bronchiolitis and viral pneumonia place tremendous strain on the health of young children and the healthcare system. The propensity of these viral infections to affect the most vulnerable of pediatric populations along with their highly variable clinical course leads to frequent hospital admissions that often occur regardless of severity \[[@B1]\]. The respiratory syncytial virus (RSV) alone affects roughly 800,000 children in the United States leading to approximately 20% of the annual birth cohort requiring medical attention yearly \[[@B2]\]. This results in \$500 million of direct hospital costs in the United States alone \[[@B3]\].

Hypoxemia requiring supplemental oxygen (O~2~) is a key determinant in the decision to hospitalize infants with bronchiolitis and contributes to increased length of stay (LOS) \[[@B4]\]. Updated clinical practice guidelines released by the American Academy of Pediatrics (AAP) in 2014 identify O~2~ supplementation and hydration as the mainstay of treatment for bronchiolitis \[[@B5]\]. They establish a blood O~2~ saturation (spO~2~) of \<90%, measured by pulse oximetry as a threshold for initiating O~2~ therapy and encourage discontinuing O~2~ supplementation and spO~2~ monitoring after improvement \[[@B6]\]. However, the integration of those guidelines can be quite challenging as they require ongoing "deimplementation," a term describing the practice of discouraging care not supported by evidence-based research \[[@B7], [@B8]\]. These practices are difficult to discourage and often need a concerted effort to eliminate, even in the face of well-executed collaboration \[[@B9]\]. While there are numerous studies evaluating the impact of deimplementing interventions such as chest X-rays, antibiotics, and corticosteroids \[[@B10]--[@B16]\], few studies specifically evaluate the impact of a protocol based O~2~ supplementation practice \[[@B17]--[@B19]\]. Our institution developed and implemented an inpatient pediatric O~2~ supplementation and pulse oximetry protocol based on AAP guidelines \[[@B5]\] that aligns with the realities of our clinical practice. We hypothesize that the implementation of this protocol and deimplementation of certain practices lead to a significant decrease in hospital LOS for children admitted with bronchiolitis.

2. Methods {#sec2}
==========

2.1. Intervention {#sec2.1}
-----------------

A multidisciplinary team of clinicians at Helen DeVos Children\'s Hospital, a tertiary care pediatric hospital, designed and implemented a standardized O~2~ supplementation and continuous pulse oximetry protocol ([Figure 1](#fig1){ref-type="fig"}) in February 2013. Significant changes to prior medical practice included lowering the threshold for O~2~ supplementation from 94% to 90% and clearly defining both the steps and duration over which O~2~ supplementation would be titrated and discontinued. This protocol created a formal algorithm that was in clear contrast to a previously highly variable system that was driven by individual care providers. We performed education in the form of online modules, didactics, and formalized multidisciplinary rounds with respiratory therapists, nurses, and providers at the hospital. We also used education to stress and deemphasize some of the practices that were not supported by clinical evidence ([Table 1](#tab1){ref-type="table"}).

2.2. Study Sample {#sec2.2}
-----------------

In order to assess this quality initiative, we performed a retrospective review of the medical charts of infants and children (≤24 months of age) hospitalized with bronchiolitis during the preintervention study period of November 1, 2011, through April 30, 2012 (control group), and during the postintervention study period of November 1, 2013, through April 30, 2014 (O~2~ protocol group). Exclusion criteria included hospital admission directly to the pediatric intensive care unit (PICU), home O~2~ used immediately before or after hospitalization, presence of a tracheostomy tube, congenital heart disease, sickle cell disease, severe anemia, hypotonia, cystic fibrosis, and age \> 24 months.

2.3. IRB Statement {#sec2.3}
------------------

Spectrum Health Institutional Review Board reviewed the study as a quality improvement (QI) project and thus was exempted from full review.

2.4. Data Sources {#sec2.4}
-----------------

The medical records of patients who met the entry criteria with discharge diagnoses of "acute bronchiolitis" were reviewed. Patients were identified using electronic medical record search queries for International Classification of Diseases, Ninth Revision (ICD-9), primary or secondary diagnosis codes 466.1 (acute bronchiolitis), 466.11 (acute bronchiolitis due to respiratory syncytial virus), and 466.19 (acute bronchiolitis due to other infectious organisms).

2.5. Study Variables {#sec2.5}
--------------------

Patient age at admission, gender, respiratory distress score (RDS), duration of supplemental O~2~, LOS, seven-day readmission rate, rate of PICU transfer, and coexisting medical problems were collected. LOS, as noted in hours, was determined as the period from the time of admission to the inpatient unit until the time of discharge. We evaluated bronchiolitis illness severity at the time of the first respiratory therapist evaluation by using a modified RDS tool, an evaluation tool based on respiratory rate, accessory muscle use, wheezing, O~2~ requirement, and inspiratory to expiratory ratio ([Table 2](#tab2){ref-type="table"}) \[[@B20]\]. RDS values ≥3 were considered to be indicative of moderate to severe bronchiolitis.

2.6. Statistical Methods {#sec2.6}
------------------------

The data was analyzed using IBM Statistics SPSS v. 21 (Armonk, New York). Quantitative data was compared using a *t*-test and was reported as the mean ± SD. Nominal data was compared using the *χ*^2^ test and Fisher\'s exact test (when appropriate) and was reported as percentages. Due to the nonnormal distribution of LOS and duration of O~2~ supplementation, both of these variables were transformed prior to analysis, while the summary statistics shown are for the untransformed data. The LOS was transformed using the natural log, while the duration of O~2~ supplementation was transformed using the inverse hyperbolic sine. In addition, a multiple regression analysis was performed, using the log transformed LOS as the dependent variable, with patient age, O~2~ protocol group versus control group, PICU transfer, and RDS score as the independent variables. Significance was assessed at *p* \< 0.05.

3. Results {#sec3}
==========

From the collective study periods, a total of 263 children met the study criteria: 141 children in the control group and 122 children in the O~2~ protocol group. [Table 3](#tab3){ref-type="table"} shows the patient\'s demographics and characteristics. There were no significant differences based on age, gender, and PICU transfer rates between control and O~2~ protocol groups ([Table 3](#tab3){ref-type="table"}). Only three children were readmitted within seven days, one in the control group and two in the O~2~ protocol group.

Contrary to our hypothesis, there was not a statistically significant difference in LOS between the control and O~2~ protocol groups. However, the O~2~ protocol group had a significantly higher severity of illness at admission based on their initial RDS independent of assessment rates.

Next, we assessed the relationship between LOS and bronchiolitis severity, as defined by the RDS. Patients in the O~2~ protocol group with mild bronchiolitis (RDS \< 3) had a statistically significant shorter LOS compared to control (RDS ≥ 3) (*p* = 0.005). Interestingly, O~2~ protocol group subjects with moderate to severe bronchiolitis (RDS ≥ 3) had a 29% increase in LOS, although this was not statistically significant (*p* = 0.535). Furthermore, O~2~ protocol group subjects with mild disease had a significantly shorter LOS compared with the O~2~ protocol patients with moderate to severe bronchiolitis ([Table 4](#tab4){ref-type="table"}). This data suggests that LOS may be dependent on disease severity. O~2~ protocol group subjects with mild bronchiolitis disproportionately improve compared with moderate to severe disease. Furthermore, the O~2~ protocol may have a negative affect when bronchiolitis is more severe. However, no direct conclusive relationship between LOS and the protocol could be inferred for moderate to severe disease due to the disproportionately higher RDS patients in the O~2~ protocol.

We performed a multiple regression analysis to independently assess each subject group and variables affecting the LOS ([Table 5](#tab5){ref-type="table"}). We found age, RDS, and PICU transfer all had a significant correlation with LOS. A one-month increase in age significantly decreased LOS. RDS significantly impacted LOS, whereas a one-unit increase in RDS significantly increased LOS by 11.3% and a two-unit increase in RDS increased LOS by 23.9%. Transfer to the PICU significantly increased LOS by 2.9 fold. The O~2~ protocol had a significant inverse association with LOS compared to the control group; patients in the O~2~ protocol group had a 19.7%, decrease in LOS ([Table 4](#tab4){ref-type="table"}).

4. Discussion {#sec4}
=============

High variability in clinical care often contributes to higher healthcare costs and poor adherence to evidence-based practices \[[@B21]\]. For this reason, health care professionals have developed protocols to drive therapies and reduce the lack of concordance. Studies have shown clinical outcomes from nonphysician directed protocols compare favorably with physician driven interventions in multiple settings \[[@B22]--[@B24]\]. Such protocols used in the PICU have the potential to save money and reduce resource allocation when used in the non-ICU setting. Our study suggests that this is potentially true. We reduced LOS for patients with mild bronchiolitis (initial RDS \< 3) after the implementation of the O~2~ protocol and deimplementation of unnecessary practices. However, LOS appeared to increase for patients with higher RDS following protocol implementation. The actual impact of RDS on LOS is somewhat confounded by the fact that RDS was higher in the postimplementation years even though the rates of assessment were similar in both groups. When we controlled for the RDS effect by using multivariate regression analysis there was a demonstrable aggregate benefit that was more than compensated for the increased LOS in sicker patients.

Deimplementation and deinnovation are quality improvement (QI) terms that emphasize the abandonment of unnecessary care that is not supported by evidence-based research \[[@B7], [@B8]\]. These terms focus on the ideal of discouraging use rather than discouraging underuse and have been used in the context of eliminating nonevidenced-based practices in bronchiolitis \[[@B9]\]. We paired the initiation of O~2~ use protocol along with deimplementation of unnecessary practices and hypothesized that a collective approach would have specific value in reducing unnecessary care. This provided a mechanism to overcome the inertia of so-called "established" clinical practice and increase the provider\'s sense of efficacy.

The AAP prioritizes the prevention of unnecessary care \[[@B5], [@B6]\], and a recent study showed benefit to eliminating practices such as X-rays and alpha-agonist therapy in community hospital settings \[[@B9]\]. The deimplementation of such practices requires constant education. It was our experience that the respiratory therapists were the strongest advocates for avoiding such unnecessary therapy. Applications of nebulized *β*-agonist therapy and/or hypertonic saline were rarely tried, and when attempted, they were discontinued once lack of efficacy was established. Such an approach has benefit in saving money, eliminating unnecessary interventions, and focusing care on the sickest during the time of the year that hospitals are busiest \[[@B25]\].

There is wide variation in the clinical course of bronchiolitis and thus it is difficult to distinguish which patients will require only titration of O~2~ therapy from those who will require a more involved escalation of care \[[@B26], [@B27]\]. For example, there have been efforts in the past to define clinical criteria that could predict inpatient LOS for children with bronchiolitis that have shown that initial spO~2~ values do not predict LOS in children with bronchiolitis \[[@B26]\]. Our protocol attempts to surmount some of that dilemma by predicating appropriate care and letting the clinical course dictate the level of care the patient receives.

This study does have limitations in that the single center retrospective design with historical controls limits our ability to conclusively state that there is benefit to the O~2~ supplementation protocol. This study design by nature is an observational study. It is possible that natural cycle of viral virulence, unknown changes to childhood immunity, and other unknown variations may affect this study. In addition, other interventions independent of this oxygen protocol may have played a role in these outcomes, in particular LOS. One criticism for our study might be that the RDS score we used is more of an amalgam of other scores available in the literature rather than a validated score. However, the score was uniformly applied to all patients, and clearly an increase in the score was associated with an increase in respiratory distress. Also, the RDS scores were notably higher on average in the O~2~ protocol group. It is possible this is due to a true difference in illness severity between the seasons evaluated, or the increased frequency of respiratory therapist monitoring mandated by the O~2~ protocol resulted in increased provider confidence in keeping patients with higher illness severity on general inpatient floors. Regardless, we presented data that the weaning protocol might have benefit in a selected group of milder bronchiolitis cases.

5. Conclusion {#sec5}
=============

This study is unique in that it highlights both the benefit and the unforeseen effect of applying protocols to patient care. Our application of the AAP guidelines in a collaborative manner saw a decrease in LOS of children with milder bronchiolitis while LOS for the sicker patients increased. However, the overall effect was one of the benefits with potential to exert an impact on appropriate hospital triage and cost. This translates into a benefit for both patients and their families.
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###### 

Clinical practices discouraged on initiation of protocol.

  ---------------------------------------------------------------------------------------------------------
  Discouraged                          Encouraged\
  ------------------------------------ --------------------------------------------------------------------
  Chest radiography                    Weaning O~2~ flow and FIO~2~

  Viral panel testing                  Accepting saturation of \>90% if child does not appear distressed\

  Blood draws for laboratory testing   Discontinuing supplemental gas flow when patient is on room air\

  *β*-Agonist therapy                  Calling the physician for any perception of deterioration\

  Steroids                             Spot checks in pulse oximetry

  Antibiotic therapy                    
  ---------------------------------------------------------------------------------------------------------

###### 

Respiratory distress score (RDS) calculation.

  Respiratory distress score
  -----------------------------------------------------------------
  Respiratory rate
   □ 0 Normal (respiratory rate (rr) up to 40 breathes/minute)
   □ 1 Elevated (RR 40--60 breaths/minute)
   □ 2 Tachypnea (RR greater than 60 breaths/minute)
  Accessory muscle use
   □ 0 Normal
   □ 1 Retractions (substernal, subcostal, intercostal)
   □ 2 Neck or abdominal muscle use
  Wheezing
   □ 0 None or scattered end expiratory wheezes
   □ 1 Wheezes throughout expiration
   □ 2 Entire inspiration and expiration wheezes
  Oxygen requirement
   □ 0 Maintains SpO~2~ above 90% on room air
   □ 1 Maintains SpO~2~ above 90% on less than 1 Lpm oxygen
   □ 2 Requires 1 Lpm oxygen or more to maintain SpO~2~ above 90%
  Inspiratory to expiratory ratio
   □ 0 I : E ratio less than 1 : 2
   □ 1 I : E ratio 1 : 2 to 1 : 3
   □ 2 I : E ratio greater than 1 : 3

###### 

Demographic and clinical variables.

  Variable                                  Control group (*n* = 141)   O~2~ protocol group (*n* = 122)   *p* value
  ----------------------------------------- --------------------------- --------------------------------- -----------
  Age (months)                              6.2 ± 5.5                   7.0 ± 6.3                         0.31
  Gender: male/female                       77 (54.6%)/64 (45.4%)       70 (57.4%)/52 (42.6%)             0.65
  RDS assessed                              125/141 (88.7%)             110/122 (90.2%)                   0.69
  RDS                                       2.0 ± 1.5                   2.7 ± 1.6                         \<0.001
  LOS (h)^a^                                69.6 ± 67.5                 72.5 ± 77.4                       0.374
   LOS: RDS \< 3^a,b^                       70.6 ± 60.3                 51.6 ± 42.6                       0.005
   LOS: RDS ≥ 3^a,c^                        74.0 ± 53.4                 95.2 ± 95.7                       0.535
  Duration of O~2~ supplementation (h)^a^   38.3 ± 58.4                 40.9 ± 62.9                       0.638
  Number requiring supplemental O~2~        134/141 (95.0%)             113/122 (92.6%)                   0.414
  PICU transfer                             10/141 (6.7%)               13/122 (9.7%)                     0.310
  7-day readmission                         1/141 (0.7%)                2/122 (1.6%)                      0.598

Data are presented as the mean ± SD or as percentages; O~2~, oxygen; LOS, length of stay; RDS, respiratory distress score; PICU, pediatric intensive care unit. ^a^Data were analyzed using log transformed data, values shown are untransformed data. ^b^Control group *n* = 87; oxygen protocol group *n* = 49. ^c^Control group *n* = 38; oxygen protocol group *n* = 61.

###### 

Study group LOS^a^ and PICU transfer compared by RDS.

  Outcome measure                  RDS \< 3 (*n* = 136)   RDS ≥ 3 (*n* = 99)   *p* value
  -------------------------------- ---------------------- -------------------- -----------
  Control group LOS (h)^b^         70.6 ± 60.3            74.0 ± 53.4          0.697
  O~2~ protocol group LOS (h)^c^   51.3 ± 41.4            92.4 ± 94.3          0.005
  PICU transfer                    9/136 (6.6%)           12/99 (12.1%)        0.144

Data are presented as the mean ± SD or as percentages; O~2~, oxygen; LOS, length of stay; RDS, respiratory distress score; PICU, pediatric intensive care unit. ^a^Data analyzed using log transformed data, values shown are untransformed data. ^b^RDS \< 3 group *n* = 87; RDS ≥ 3 group *n* = 38; ^c^RDS \< 3 group *n* = 49; RDS ≥ 3 group *n* = 61.

###### 

Multiple regression analysis, with log transformed length of stay (LOS) as the dependent variable.

  ------------------------------------------------------------------------
  Variable                   *β*-Coefficient   95% CI         *p* value\
  -------------------------- ----------------- -------------- ------------
  O~2~ protocol group^*∗*^   −0.22              \             0.030
                                               −0.42--−0.02   

  Age                        −0.02             −0.04--−0.01   0.008

  RDS                        0.11              0.04--0.17     0.001

  PICU Transfer              1.06              0.72--1.41     \<0.001
  ------------------------------------------------------------------------

CI, confidence interval; O~2~, oxygen; RDS, respiratory distress score; PICU, pediatric intensive care unit. ^*∗*^Control group (reference group) versus the O~2~ protocol group.
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